Oncopeptides AB
F:OND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncopeptides AB
F:OND
|
SE |
|
sino AG
F:XTP
|
DE |
|
Hingham Institution For Savings
F:HS3
|
US |
|
Tirupati Graphite PLC
F:0WL
|
UK |
|
Nordic Paper Holding AB
F:NPH
|
SE |
|
D
|
DOWA Holdings Co Ltd
DUS:DMI
|
JP |
|
Melco International Development Ltd
F:MX7A
|
HK |
|
Y
|
YouGov PLC
F:Y1G
|
UK |
|
Sipef NV
F:BZ3
|
BE |
|
H
|
Hokuetsu Corp
F:HPE
|
JP |
|
E
|
Esprit Holdings Ltd
DUS:ESHB
|
HK |
|
Q
|
Quartiers Properties AB (publ)
STO:QUART
|
SE |
|
Mission Group PLC
F:M7K
|
UK |
|
A
|
A2 Milk Company Ltd
F:14L
|
NZ |
|
Investar Holding Corp
F:7ZH
|
US |
|
W
|
Wuling Motors Holdings Ltd
OTC:WLMTF
|
HK |
|
T
|
Toyo Kanetsu KK
F:TQ2
|
JP |
Bankruptcy Probability
Oncopeptides AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oncopeptides AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Oncopeptides AB
STO:ONCO
|
678.4m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oncopeptides AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oncopeptides AB has total debt of 130.8m SEK. This includes both short-term (0 SEK) and long-term (130.8m SEK) debt.
You can find a full breakdown on its Balance Sheet.
